Rhode Island Hospital joins national Alzheimer’s disease imaging study

DR. BRIAN R. OTT, left, director at the Alzheimer's Disease & Memory Disorders Center at Rhode Island Hospital and Lori A. Daiello research scientist and clinical research administrator. PBN FILE PHOTO/MICHAEL SALERNO
PROVIDENCE — Rhode Island Hospital has joined phase four of the $40 million Alzheimer’s Disease Neuroimaging Initiative, an international clinical trial studying the rate of brain function changes as people age past 55, which will guide Alzheimer’s treatment research. The trial, mainly funded by the National Institutes of Health at $40 million, with up to…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display